Laboratory News and Research

RSS

Beckman Coulter launches DURA Innovations global flow cytometry business tools

Beckman Coulter Life Sciences expands services by placing DURA Innovations dry reagent solutions at the heart of enhanced external business resources for lab.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

Beckman Coulter introduces expanded range of clinical flow cytometry solutions at AACC 2018

Beckman Coulter continues to expand portfolio of clinical flow cytometry solutions with its latest innovations.

From Beckman Coulter Life Sciences - Flow Cytometry 30 Jul 2018

New device uses single drop of blood to diagnose mild traumatic brain injury

Every year in Europe, three million people are admitted into hospitals for suspected mild traumatic brain injury cases. Yet 90% of these patients will be able to return home safely, as no trauma has been detected.

30 Jul 2018

Alcala Labs to use Neoteryx’s VAMS technology for monitoring patients in recovery centers

Today, Neoteryx LLC, announced that it will supply its Volumetric Absorptive Microsampling technology, in the form of the Mitra microsampling device, to Alcala Labs of San Diego for a more efficacious, streamlined approach to monitor patients in recovery centers throughout the United States.

28 Jul 2018

New study provides insight into how stimulant treatments for ADHD work

Stimulant medications are an effective treatment for Attention-Deficit/Hyperactivity Disorder. In the classroom, parents and teachers say that medications like methylphenidate can reduce symptoms and improve behavior.

28 Jul 2018

New approach shows important role of microRNAs in papillomavirus life cycle

The discovery of microRNAs encoded by papillomaviruses supports the important role of these small molecules in persistent infection, according to a study published July 26 in the open-access journal PLOS Pathogens.

27 Jul 2018

New study aims to develop nucleoside therapy as treatment for mitochondrial depletion syndromes

Hundreds of types of mitochondrial disease affect up to 38 million people worldwide, yet there are very few effective treatments, forcing patients and doctors to rely on symptom management to battle the serious and potentially fatal genetic disorder that starves the body’s cells of energy.

27 Jul 2018

Philips and Oxford University Hospitals NHS Foundation Trust join hands to set up digital pathology network

Royal Philips, a global leader in health technology, and Oxford University Hospitals (OUH) NHS Foundation Trust, today announced plans to create a digital pathology network to help drive faster and more efficient diagnoses for patients.

From Philips Healthcare 27 Jul 2018

Artificial intelligence used to demonstrate link between personality and eye movements

It's often been said that the eyes are the window to the soul, revealing what we think and how we feel. Now, new research reveals that your eyes may also be an indicator of your personality type, simply by the way they move.

27 Jul 2018

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis today announced the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending approval of Tafinlar® in combination with Mekinist® for the adjuvant treatment of adult patients with stage III melanoma with a BRAF V600 mutation, following complete resection.

27 Jul 2018

Study shows how organs acquire very complex yet stable shapes

Researchers from the Department of Cellular Biology at the University of Seville and Seville Institute of Biomedicine have shown that epithelial cells, which are those that cover the surfaces of many organs, adopt a new, previously undescribed geometric shape, the scutoid, so that tissue can curve.

27 Jul 2018

Researchers discover novel antibiotic from leaf of common weed

Researchers working on an SNSF project have discovered novel, antibiotically active chemical substances in a previously rarely explored site: the leaf of a common field weed.

27 Jul 2018

PEACHI project develops vaccine strategies targeting both HIV and hepatitis C virus

An estimated 2.3 million people globally are infected with both human immunodeficiency virus type 1 and hepatitis C virus.

27 Jul 2018

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

UCSF Benioff Children's Hospital Oakland clinical researchers, in conjunction with other sickle cell centers and scientists at Emmaus Life Sciences, Inc., have demonstrated that therapy with L-Glutamine reduced the frequency of pain episodes in both pediatric and adult patients with sickle cell disease.

27 Jul 2018